HSA Product

NATZO 8 TABLETS 8 mg

Product approved by Health Sciences Authority (SG)

Basic Information

Product Name

NATZO 8 TABLETS 8 mg

Dosage Form

TABLET

Regulatory Information

Approval Number

SIN15424P

Approval Date

February 9, 2018

Forensic Classification

Prescription Only

Drug Type

Therapeutic

Route of Administration

ORAL

Record Created

August 10, 2023

Last Updated

May 30, 2025

ATC Business ID

XA04AA01

Company Information

ManufacturerNatco Pharma Limited - Pharma Division

Registrant

NATCO PHARMA ASIA PTE. LTD.

Licence Holder

NATCO PHARMA ASIA PTE. LTD.

Active Ingredients

Ondansetron Hydrochloride Dihydrate 10 mg EQV Ondansetron

Strength: 8.0 mg

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy